haku: @indexterm medicine / yhteensä: 97
viitteet: 11-20 / 97
« edellinen sivu | seuraava sivu »
 otsikkovuositekijä
11.
Testing drugs on animals: a test case for socially responsible investment
Business Ethics
2005 : APR, VOL 14:2, p. 164-175
 2005 Taylor, R.
12.
International pricing and distribution of therapeutic pharmaceuticals - an ethical minefield
Business Ethics
2005 : APR, VOL 14:2, p. 127-141
 2005 Buckley, J.
Tuama, S. Ó.
13.
A model for addressing stakeholders' concerns about direct-to-consumer advertising of prescription medicines
European Journal of Marketing
2005 : VOL. 39:9-10, p. 1151-1165
 2005 Hoek, J.
Maubach, N.
14.
The challenges for neuroscience in ad research
Admap
2005 : SEP, VOL 40:8, p. 36-38
 2005 Page, G.
15.
Could brain science be peace broker in the 'Recall Wars'?
Admap
2005 : SEP, VOL 40:8, p. 33-35
 2005 Penn, D.
16.
Price controls or control through prices? Regulating the cost and consumption of prescription pharmaceuticals in the UK, 1948-67
Business history
2005 : JULY, VOL. 47:3, p. 352-366
 2005 Slinn, J.
17.
Attitudes towards DTC advertisind in Australia : an exploratory study
International Journal of Advertising
2004 : VOL. 23:3, p. 389-405
 2004 Miller, K. E.
Waller, D. S.
18.
Model selection for medical diagnosis decision support systems
Decision Support Systems
2004 : JAN, VOL. 36:3, p. 247-259
 2004 Mangiameli, P.
West, D.
Rampal, R.
19.
Prescription medication advertising: professional discomfort and potential patient benefits - can the two be balanced?
International Journal of Advertising
2004 : VOL. 23:1, p. 69-90
 2004 Eagle, L.
Chamberlain, K.
20.
Consumers' attention to the brief summary in print direct-to-consumer advertisements: perceived usefulness in patient-physician discussions
Journal of Public Policy and Marketing
2003 : FALL. VOL. 22:2, p. 181-191
 2003 Menon, A.M. (et al.)
« edellinen sivu | seuraava sivu »
SCIMA